Innovative medical devices for diagnostic and ear/nose/throat (ENT) conditions. (Q104058): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): The purpose of the project is the development of liquid medical devices to be used for periodontal conditions (DRS 1) and ear/nose/throat (IRRS 2), with registration potential, as medical devices in Class III. In addition, a pilot apparatus will be created to validate the process of filling the product filling process into a syringe in 1, the action of which is assisted by the dosage of the fluid under pressure. The Action Mechanism 1. consist...) |
(Created claim: summary (P836): The aim of the project is to develop liquid medical devices for use in periodontological diseases (SECTION 1) and laryngological devices (SEAR 2), which have the potential for registration as Class III medical devices. In addition, for Product 1, the operation of which will be aided by dispensing the liquid under pressure, a pilot apparatus will be created to validate the filling process of the product into syringe dispensers. The mechanism of a...) |
||||||||||||||
| Property / summary | |||||||||||||||
The aim of the project is to develop liquid medical devices for use in periodontological diseases (SECTION 1) and laryngological devices (SEAR 2), which have the potential for registration as Class III medical devices. In addition, for Product 1, the operation of which will be aided by dispensing the liquid under pressure, a pilot apparatus will be created to validate the filling process of the product into syringe dispensers. The mechanism of action of Product 1 consists of mechanical removal of inflammatory content from gum pockets created, among others, in the area of class II fillings, in the area of teeth with difficult cutting, after removal of dental stone or under prosthetic work of the type of bridge or crown. On the other hand, Product 2 will combine the mechanical effects of the device (as a physical barrier against the adhesion and penetration of bacteria and viruses) with an auxiliary pharmacologically active substance with antimicrobial action. Implementation of the Project will last for 36 months through two tasks: 1) Conduct of industrial research related to R & D work on Product 1 and Product 2 and 2) Experimental development work related to product 1 and Product 2. The project assumes the implementation of indicators at the level of the result: 1. Number of patent applications made; 2. Revenue from the sale of new or improved products/processes; 3. Number of newly created jobs – other forms. At product level: 1. Number of enterprises receiving support; 2. Number of enterprises receiving grants; 3. Private investment complementing public support to enterprises (grants); 4. Number of companies cooperating with research centres; 5. Number of enterprises investing in R & D activities; 6. Number of R & D projects implemented; 7. Number of enterprises supported in R & D activities. (English) | |||||||||||||||
| Property / summary: The aim of the project is to develop liquid medical devices for use in periodontological diseases (SECTION 1) and laryngological devices (SEAR 2), which have the potential for registration as Class III medical devices. In addition, for Product 1, the operation of which will be aided by dispensing the liquid under pressure, a pilot apparatus will be created to validate the filling process of the product into syringe dispensers. The mechanism of action of Product 1 consists of mechanical removal of inflammatory content from gum pockets created, among others, in the area of class II fillings, in the area of teeth with difficult cutting, after removal of dental stone or under prosthetic work of the type of bridge or crown. On the other hand, Product 2 will combine the mechanical effects of the device (as a physical barrier against the adhesion and penetration of bacteria and viruses) with an auxiliary pharmacologically active substance with antimicrobial action. Implementation of the Project will last for 36 months through two tasks: 1) Conduct of industrial research related to R & D work on Product 1 and Product 2 and 2) Experimental development work related to product 1 and Product 2. The project assumes the implementation of indicators at the level of the result: 1. Number of patent applications made; 2. Revenue from the sale of new or improved products/processes; 3. Number of newly created jobs – other forms. At product level: 1. Number of enterprises receiving support; 2. Number of enterprises receiving grants; 3. Private investment complementing public support to enterprises (grants); 4. Number of companies cooperating with research centres; 5. Number of enterprises investing in R & D activities; 6. Number of R & D projects implemented; 7. Number of enterprises supported in R & D activities. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The aim of the project is to develop liquid medical devices for use in periodontological diseases (SECTION 1) and laryngological devices (SEAR 2), which have the potential for registration as Class III medical devices. In addition, for Product 1, the operation of which will be aided by dispensing the liquid under pressure, a pilot apparatus will be created to validate the filling process of the product into syringe dispensers. The mechanism of action of Product 1 consists of mechanical removal of inflammatory content from gum pockets created, among others, in the area of class II fillings, in the area of teeth with difficult cutting, after removal of dental stone or under prosthetic work of the type of bridge or crown. On the other hand, Product 2 will combine the mechanical effects of the device (as a physical barrier against the adhesion and penetration of bacteria and viruses) with an auxiliary pharmacologically active substance with antimicrobial action. Implementation of the Project will last for 36 months through two tasks: 1) Conduct of industrial research related to R & D work on Product 1 and Product 2 and 2) Experimental development work related to product 1 and Product 2. The project assumes the implementation of indicators at the level of the result: 1. Number of patent applications made; 2. Revenue from the sale of new or improved products/processes; 3. Number of newly created jobs – other forms. At product level: 1. Number of enterprises receiving support; 2. Number of enterprises receiving grants; 3. Private investment complementing public support to enterprises (grants); 4. Number of companies cooperating with research centres; 5. Number of enterprises investing in R & D activities; 6. Number of R & D projects implemented; 7. Number of enterprises supported in R & D activities. (English) / qualifier | |||||||||||||||
point in time: 17 October 2020
| |||||||||||||||
Revision as of 16:20, 17 October 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Innovative medical devices for diagnostic and ear/nose/throat (ENT) conditions. |
Project in Poland financed by DG Regio |
Statements
1,928,682.91 zloty
0 references
2,552,050.91 zloty
0 references
75.57 percent
0 references
1 August 2017
0 references
31 July 2020
0 references
ARKONA LABORATORIUM FARMAKOLOGII STOMATOLOGICZNEJ GRZEGORZ KALBARCZYK
0 references
Celem realizacji projektu jest opracowanie płynnych wyrobów medycznych do zastosowania w schorzeniach periodontologicznych (WYRÓB 1) i laryngologicznych (WYRÓB 2), mających potencjał rejestracyjny, jako wyroby medyczne klasy III. Dodatkowo, dla Wyrobu 1, którego działanie wspomagane będzie przez dozowanie płynu pod ciśnieniem, stworzona zostanie pilotażowa aparatura umożliwiająca walidację procesu napełniania wyrobu do dozowników strzykawkowych. Mechanizm działania Wyrobu 1. polega na mechanicznym usunięciu treści zapalnej z kieszonek dziąsłowych powstałych m.in. w okolicach wypełnień klasy II, w okolicach zębów z utrudnionym wyrzynaniem, po usunięciu kamienia nazębnego czy pod pracami protetycznymi typu mosty lub korony. Natomiast Wyrób 2. będzie łączył działanie mechaniczne wyrobu (jako bariery fizycznej przed przyleganiem i wnikaniem bakterii i wirusów) z pomocniczym działaniem substancji farmakologicznie czynnej o działaniu przeciwdrobnoustrojowym. Realizacja Projektu trwać będzie przez 36 miesięcy poprzez realizacji dwóch zadań: 1) Przeprowadzenie badań przemysłowych związanych z pracami badawczo-rozwojowymi nad Wyrobem 1 oraz Wyrobem 2 oraz 2) Przeprowadzenie eksperymentalnych prac rozwojowych związanych z pracami badawczo-rozwojowymi nad Wyrobem 1 oraz Wyrobem 2. Projekt zakłada realizację wskaźników na poziomie rezultatu: 1. Liczba dokonanych zgłoszeń patentowych; 2. Przychody ze sprzedaży nowych lub udoskonalonych produktów/procesów; 3. Liczba nowo utworzonych miejsc pracy - pozostałe formy. Na poziomie produktu: 1. Liczba przedsiębiorstw otrzymujących wsparcie; 2. Liczba przedsiębiorstw otrzymujących dotacje; 3. Inwestycje prywatne uzupełniające wsparcie publiczne dla przedsiębiorstw (dotacje); 4. Liczba przedsiębiorstw współpracujących z ośrodkami badawczymi; 5. Liczba przedsiębiorstw ponoszących nakłady inwestycyjne na działalność B+R; 6. Liczba realizowanych projektów B+R; 7. Liczba przedsiębiorstw wspartych w zakresie prowadzenia prac B+R. (Polish)
0 references
The aim of the project is to develop liquid medical devices for use in periodontological diseases (SECTION 1) and laryngological devices (SEAR 2), which have the potential for registration as Class III medical devices. In addition, for Product 1, the operation of which will be aided by dispensing the liquid under pressure, a pilot apparatus will be created to validate the filling process of the product into syringe dispensers. The mechanism of action of Product 1 consists of mechanical removal of inflammatory content from gum pockets created, among others, in the area of class II fillings, in the area of teeth with difficult cutting, after removal of dental stone or under prosthetic work of the type of bridge or crown. On the other hand, Product 2 will combine the mechanical effects of the device (as a physical barrier against the adhesion and penetration of bacteria and viruses) with an auxiliary pharmacologically active substance with antimicrobial action. Implementation of the Project will last for 36 months through two tasks: 1) Conduct of industrial research related to R & D work on Product 1 and Product 2 and 2) Experimental development work related to product 1 and Product 2. The project assumes the implementation of indicators at the level of the result: 1. Number of patent applications made; 2. Revenue from the sale of new or improved products/processes; 3. Number of newly created jobs – other forms. At product level: 1. Number of enterprises receiving support; 2. Number of enterprises receiving grants; 3. Private investment complementing public support to enterprises (grants); 4. Number of companies cooperating with research centres; 5. Number of enterprises investing in R & D activities; 6. Number of R & D projects implemented; 7. Number of enterprises supported in R & D activities. (English)
17 October 2020
0 references
Identifiers
RPLU.01.02.00-06-0044/17
0 references